Anna Peroni1, Chiara Colato2, Donatella Schena1, Franco Rongioletti3, Giampiero Girolomoni4. 1. Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy. 2. Department of Pathology and Diagnostics, Section of Pathology, University of Verona, Verona, Italy. 3. Department of Health Sciences, Section of Dermatology, University of Genoa, Genoa, Italy. 4. Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy. Electronic address: giampiero.girolomoni@univr.it.
Abstract
BACKGROUND: Histiocytoid Sweet syndrome (HSS) is a rare variant of Sweet syndrome (SS). The nature of histiocytoid cells is still uncertain. OBJECTIVE: We sought to offer a comprehensive overview on clinical features of HSS and further information on immunohistochemical phenotype of the infiltrate. METHODS: The clinical, histologic, and immunohistochemical features of 12 of our patients with HSS and all cases retrieved through a PubMed search were analyzed. RESULTS: Lesions consisted of erythematous-violaceous papules and plaques, randomly distributed mostly on the trunk and the limbs. Three patients had myelodysplastic syndrome and 1 had a monoclonal gammopathy. The infiltrate was mainly composed of CD68(+)CD163(+)myeloperoxidase(+)myeloid cell nuclear differentiation antigen(+)CD117(-)CD15(-)CD34(-), a phenotype suggestive of M2-like macrophages. A few mature neutrophils and lymphocytes were also present. Review of all HSS cases showed no sex predominance and no extracutaneous infiltrates; inconstant presence of fever and blood neutrophilia; association with hematologic or solid neoplasms (26%), autoimmune conditions (12%), and infectious diseases (10%); and good response to steroid treatment, with rare relapses or recurrences. LIMITATIONS: The study includes a limited case series. The pathogenesis of the disease remains to be clarified. CONCLUSIONS: HSS lesions are infiltrated mostly by M2-like macrophages. The clinical features present more similarities than differences with SS.
BACKGROUND: Histiocytoid Sweet syndrome (HSS) is a rare variant of Sweet syndrome (SS). The nature of histiocytoid cells is still uncertain. OBJECTIVE: We sought to offer a comprehensive overview on clinical features of HSS and further information on immunohistochemical phenotype of the infiltrate. METHODS: The clinical, histologic, and immunohistochemical features of 12 of our patients with HSS and all cases retrieved through a PubMed search were analyzed. RESULTS: Lesions consisted of erythematous-violaceous papules and plaques, randomly distributed mostly on the trunk and the limbs. Three patients had myelodysplastic syndrome and 1 had a monoclonal gammopathy. The infiltrate was mainly composed of CD68(+)CD163(+)myeloperoxidase(+)myeloid cell nuclear differentiation antigen(+)CD117(-)CD15(-)CD34(-), a phenotype suggestive of M2-like macrophages. A few mature neutrophils and lymphocytes were also present. Review of all HSS cases showed no sex predominance and no extracutaneous infiltrates; inconstant presence of fever and blood neutrophilia; association with hematologic or solid neoplasms (26%), autoimmune conditions (12%), and infectious diseases (10%); and good response to steroid treatment, with rare relapses or recurrences. LIMITATIONS: The study includes a limited case series. The pathogenesis of the disease remains to be clarified. CONCLUSIONS:HSS lesions are infiltrated mostly by M2-like macrophages. The clinical features present more similarities than differences with SS.
Authors: Victoria Alegría-Landa; Socorro María Rodríguez-Pinilla; Angel Santos-Briz; José Luis Rodríguez-Peralto; Victor Alegre; Lorenzo Cerroni; Heinz Kutzner; Luis Requena Journal: JAMA Dermatol Date: 2017-07-01 Impact factor: 10.282
Authors: Seung Dohn Yeom; Hye Soo Ko; Jong Hyuk Moon; Min Ji Kang; Ji Won Byun; Gwang Seong Choi; Jeonghyun Shin Journal: Ann Dermatol Date: 2017-08-25 Impact factor: 1.444
Authors: R Mahieu; L Tillard; H Le Guillou-Guillemette; E Vinatier; P Jeannin; A Croué; Y Le Corre; Y-M Vandamme Journal: J Eur Acad Dermatol Venereol Date: 2020-06-30 Impact factor: 9.228